SCHEDULE: Steadfast Capital Discloses 7.3% Stake in 180 Life Sciences
Beneficial Ownership Report
Steadfast Capital Management LP and its affiliates reported a passive beneficial ownership of 7.3% in 180 Life Sciences Corp.'s common stock.
Summary
- Steadfast Capital Management LP, American Steadfast, L.P., Steadfast International Master Fund Ltd., and Robert S. Pitts, Jr. (collectively, the "Reporting Persons") have filed a Schedule 13G.
- The Reporting Persons collectively beneficially own 11,320,754 shares of 180 Life Sciences Corp. Common Stock.
- This aggregate ownership represents 7.3% of the Issuer's outstanding Common Stock.
- The percentage is calculated based on 154,032,084 shares of Common Stock outstanding as of August 4, 2025, as reported in the Issuer's Form 8-K filed on August 5, 2025.
- Steadfast Capital Management LP and Robert S. Pitts, Jr. each beneficially own 11,320,754 shares, representing 7.3% of the outstanding Common Stock.
- American Steadfast, L.P. beneficially owns 4,109,434 shares, representing 2.7% of the outstanding Common Stock.
- Steadfast International Master Fund Ltd. beneficially owns 7,211,320 shares, representing 4.7% of the outstanding Common Stock.
- The Reporting Persons have shared voting and dispositive power over the shares.
Sentiment
Score: 5
Explanation: The filing is a standard passive beneficial ownership report (Schedule 13G), indicating a significant but non-controlling stake. It is neutral in sentiment as it does not convey positive or negative operational or financial news about the issuer, nor does it suggest an activist intent.
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by a prominent capital management firm in a life sciences company. Such disclosures are routine for institutional investors crossing specific ownership thresholds and typically do not imply strategic shifts or direct operational involvement, especially when explicitly stating the stake is not for control.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holder like Steadfast Capital Management LP may be viewed positively by some investors as a vote of confidence, while others may monitor for potential future changes in the stake.
Key Dates
| Date | Description |
|---|---|
| 08/04/2025 | Date of event which requires the filing of this statement (beneficial ownership threshold met). |
| 08/05/2025 | Date of Issuer's Current Report on Form 8-K, which reported the total shares outstanding used for percentage calculation. |
| 08/12/2025 | Date the Schedule 13G was signed and filed. |
Keywords
180 Life Sciences Corp, Steadfast Capital Management, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Schedule 13G, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.